Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus

Journal of Hepatology

Volumn 26, Issue 5, 1997, Pages 975-982

  Toyoda, Hidenori ^a   Fukuda, Hoshihide ^a   Koyama, Yasuo ^a   Takamatsu, Junki ^a   Saito, Hidehiko ^a   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

HCV; HIV; Immunosuppression; Quasispecies population

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HELPER CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SPECIES DIFFERENCE; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

EID: 0030993616     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(97)80105-5     Document Type: Article

References (46)

1. Makris M, Garson JA, Ring CJA. Hepatitis C viral RNA in clotting factor concentrates and the development of hepatitis in recipients. Blood. 81:1993;1898-1902.
2. Eyster ME, Diamondstone LS, Lien J-M, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multi-transfused hemophiliacs: effect of coinfection with human immunochemistry virus. J AIDS. 6:1993;602-610.
3. Isobe K, Imoto M, Fukuda Y, Koyama Y, Nakano I, Hayakawa T, Takamatsu J. Hepatitis C virus infection and genotypes in Japanese hemophiliacs. Liver. 15:1995;131-134.
4. Martin P, Di Bisceglie AM, Kassianides C, Lisker-Melman M, Hoofnagle JH. Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. Gastroenterology. 97:1989;1559-1561.
5. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers. An application to clinical surveys and tracing infection sources. J Gen Virol. 73:1992;673-679.
6. Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C viruses in Japan. Biochem Biophys Res Commun. 170:1990;1021-1025.
7. Tsukiyama-Kohara K, Yamaguchi K, Maki N, Ohta Y, Miki K, Ohba K, Tanaka S, Hattori N, Nomoto A, Kohara M. Antigenicities of group I and II hepatitis C virus polypeptides: molecular basis of diagnosis. Virology. 192:1993;430-437.
8. Houghton M, Weiner A, Han J, Kuo G, Choo Q-L. Molecular biology of the hepatitis C viruses: implications for diagnosis, development and control of viral diseases. Hepatology. 14:1991;381-388.
9. Cha TA, Beall E, Irvine B, Kolberg J, Chien D, Kuo G, Urdea MS. At least five related, but distinct, hepatitis C viral genotypes exist. Proc Natl Acad Sci USA. 89:1992;7144-7148.
10. Chan S-W, McOmish F, Holmes EC, Dow B, Peutherer JF, Follett E, Yap PL, Simmonds P. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol. 73:1992;1131-1141.
11. Simmonds P, McOmish F, Yap PL, Chan S-W, Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5′ non coding region of hepatitis C viruses: identification of a new virus type and restriction on sequence diversity. J Gen Virol. 74:1993;661-668.
12. Okamoto H, Kurai K, Okada S, Yamamoto K, Iizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology. 188:1992;33141.
13. Mori S, Kato N, Yagyu A, Tanaka T, Ikeda Y, Petchclai B, Chiewsilp P, Kurimura T, Shimotohno K. A new type of hepatitis C virus in patients in Thailand. Biochem Biophys Res Commun. 183:1992;334-342.
14. Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA. 87:1990;9524-9528.
15. Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, Andoh T, Toshida I, Okayama H. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol. 65:1991;1105-1113.
16. Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, Coit D, Medina-Selby A, Barr PJ, Weiner AJ, Bradley DW, Kuo G, Houghton M. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA. 88:1991;2451-2455.
17. Oshima M, Tsuchiya M, Yagasaki M, Orita T, Hasegawa M, Tomonoh K, Kojima T, Hirata Y, Yamamoto O, Sho Y, Maeda E, Arima T. cDNA clones of Japanese hepatitis C virus genomes derived from a single patient show sequence heterogeneity. J Gen Virol. 72:1991;2805-2809.
18. Martell M, Esteban JI, Quer J, Genesca J, Weiner A, Esteban R, Guardia J, Gomez J. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 66:1992;3225-3229.
19. Murakawa K, Esumi M, Kàto T, Kambara H, Shikata T. Heterogeneity within the nonstructural protein 5-encoding region of hepatitis C viruses from a single patients. Gene. 117:1992;229-232.
20. Enomoto N, Kurosaki M, Tanaka Y, Marumo F, Sato C. Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. J Gen Virol. 75:1994;1361-1369.
21. Weiner AJ, Geysen HM, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, Crawford K, Marion CD, Crawford KA, Brunetto M, Barr PJ, Miyamura T, McHutchinson J, Houghton M. Evidence for immune selection of hepatitis C virus putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA. 89:1992;3468-3472.
22. Shibata M, Morishima T, Kudo T, Maki T, Maki S, Nagai Y. Serum hepatitis C virus sequences in post-transfusion non-A, non-B hepatitis. Blood. 77:1991;1157-1160.
23. Stuyver L, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Heuverswyn HV, Maertens G. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol. 74:1993;1093-1102.
24. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan S-W, Chayama K, Chen D-S, Choo Q-L, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fay O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hotta H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau JYN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea M. A proposed system for the nomenclautre of hepatitis C viral genotypes. Hepatology. 19:1994;1321-1324.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
26. Lau JYN, Davis GL, Kniffen J, Qian K-P, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet. 341:1993;1501-1504.
27. Sanchez-Pescador R, Sheridan PJ, Detmer JJ, Hunt WP, Chan CS, Wright T, Okano A, Wilber JC, Neuwald PD, Urdea MS. Quantitative detection of HCV-RNA in human sera using a chemoluminescent signal amplification oligonucleotide probe assay. Hepatology. 16:1992;588. (Abstract).
28. Schulhof JC, Molko D, Teoule R. The final deprotection step in oligonucleotide synthesis is reduced to a mild and rapid ammonia treatment by using labile base-protecting groups. Nucleic Acid Res. 15:1987;397-416.
29. Sambrook J, Fritsch EF, Maniatis T. 2nd edn. Molecular cloning. 1989;8.11-8.14 Springs Harbor Laboratory, New York.
30. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics. 5:1989;874-879.
31. Makino R, Yazyu H, Kishimoto Y, Sekiya T, Hayashi K. F-SSCP: Fluorescence-based polymerase chain reaction - single-strand conformation polymorphism (PCR-SSCP) analysis. PCR Methods Applic. 2:1992;10-13.
32. Hultman T, Stahl S, Hornes E, Uhlen M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acid Res. 17:1989;4937-4946.
33. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 74:1977;5463-5467.
34. Bachmann B, Luke W, Hunsmann G. Improvement of PCR amplified DNA sequencing with the aid of detergents. Nucleic Acid Res. 18:1990;1309.
35. van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, DiNello R, van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie PN. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 337:1991;317-319.
36. Ragni MV, Ndimbie OK, Rice EO, Bontempo FA, Nedjar S. The presence of hepatitis C virus (HCV) antibody in human immunodeficiency virus-positive hemophilic men undergoing HCV "seroversion" Blood. 82:1993;1010-1015.
37. Guido M, Rugge M, Fattovich G, Rocchetto P, Cassaro M, Chemello L, Noventa F, Giustina G, Alberti A. Human immunodeficiency virus infection and hepatitis C pathology. Liver. 14:1994;314-319.
38. Sherman KE, O'Brien J, Gutierrez AG, Harrison S, Urdea M, Neuwald P, Wilber J. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol. 31:1993;2679-2682.
39. Wright TL, Hollander H, Pu X, Held MJ, Lipson P, Quan S, Polito S, Thaler MM, Bacchetti P, Scharschmidt BF. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology. 20:1994;1152-1155.
40. Cribier B, Rey D, Schmitt C, Lang J-M, Kirn A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS. 9:1995;1131-1136.
41. Berger A, von Depka Prondzinski M, Doerr HW, Rabenau H, Weber B. Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection. J Med Virol. 48:1996;339-343.
42. Toyoda H, Nakano S, Kumada T, Takeda I, Sugiyama K, Osada T, Kiriyama S, Orito E, Mizokami M. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-α therapy in chronic hepatitis C patients. J Med Virol. 48:1996;354-359.
43. Orito E, Mizokami M, Nakano T, Terashima H, Nojiri O, Sakakibara K, Mizuno M, Ogino M, Nakamura M, Matsumoto Y, Miyata K, Lau JYN. Serum hepatitis C virus RNA levels as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C. J Med Virol. 44:1994;410-414.
44. Toyoda H, Fukuda Y, Koyama Y, Nakano I, Kinoshita M, Hadama T, Junki T, Hayakawa T. Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C. Blood. 88:1996;1488-1493.
45. Sherman KE, Andreatta C, O'Brien J, Gutierrez A, Harris R. Hepatitis C in human immunodeficiency virus-coinfected patients: increased variability in the hypervariable envelope coding domain. Hepatology. 23:1996;688-694.
46. Kumar U, Monjardino J, Thomas HC. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology. 106:1994;1072-1075.